Massachusetts General Hospital-Cancer Center — Boston, Massachusetts

Massachusetts General Hospital-Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital-Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Advanced Ovarian Carcinoma, Fallopian Tube Carcinoma.

Sponsors: Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital-Cancer Center?

Massachusetts General Hospital-Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital-Cancer Center conducted?

Massachusetts General Hospital-Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Advanced Ovarian Carcinoma, Fallopian Tube Carcinoma.

Is Massachusetts General Hospital-Cancer Center accredited by Crixeo Health?

Massachusetts General Hospital-Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital-Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.